|
Market Cap (3-Jul) $356,619,552 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (19-Jun) 27,150,697 (1.86%) (138th) |
|
52w High $0.415 |
52w Low $0.223 |
P/E 7.50 |
EPS -0.03 |
IMM released this announcement to the ASX on 17 November 2022, 10:58. The announcement is not marked as price sensitive, and is 11 page(s) in length and 685.16kb in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 0.595% short sold according to ASIC data. It was ranked the 303rd most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| Immutep Investor Update | 17 November 2022, 10:58 |
| Immutep receives A$1 million R&D Tax Incentive | 14 November 2022, 9:18 |
| Immutep Webcast to discuss clinical data presented at SITC | 11 November 2022, 8:16 |
| TACTI-002 data presented at SITC for Efti in 1st line NSCLC | 11 November 2022, 8:16 |
You must be logged in to post a reply.
